| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |